189 related articles for article (PubMed ID: 7541331)
1. Specific staining of iododeoxyuridine and bromodeoxyuridine in tumors double labelled in vivo: a cell kinetic analysis.
Pollack A; Terry NH; Wu CS; Wise BM; White RA; Meistrich ML
Cytometry; 1995 May; 20(1):53-61. PubMed ID: 7541331
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of two incorporated halogenated thymidine analogues and DNA in a mouse mammary tumor grown in vivo.
Pollack A; Terry NH; Van NT; Meistrich ML
Cytometry; 1993; 14(2):168-72. PubMed ID: 8440150
[TBL] [Abstract][Full Text] [Related]
3. An indirect immunofluorescence double staining procedure for the simultaneous flow cytometric measurement of iodo- and chlorodeoxyuridine incorporated into DNA.
Bakker PJ; Stap J; Tukker CJ; van Oven CH; Veenhof CH; Aten J
Cytometry; 1991; 12(4):366-72. PubMed ID: 2065560
[TBL] [Abstract][Full Text] [Related]
4. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer.
Lawrence TS; Davis MA; Maybaum J; Mukhopadhyay SK; Stetson PL; Normolle DP; McKeever PE; Ensminger WD
Cancer Res; 1992 Jul; 52(13):3698-704. PubMed ID: 1617642
[TBL] [Abstract][Full Text] [Related]
5. Discrimination of bromodeoxyuridine labelled and unlabelled mitotic cells in flow cytometric bromodeoxyuridine/DNA analysis.
Jensen PO; Larsen JK; Christensen IJ; van Erp PE
Cytometry; 1994 Feb; 15(2):154-61. PubMed ID: 8168402
[TBL] [Abstract][Full Text] [Related]
6. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
7. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW
Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629
[TBL] [Abstract][Full Text] [Related]
9. Tumor cell kinetics using two labels and flow cytometry.
Ritter MA; Fowler JF; Kim YJ; Gilchrist KW; Morrissey LW; Kinsella TJ
Cytometry; 1994 May; 16(1):49-58. PubMed ID: 8033734
[TBL] [Abstract][Full Text] [Related]
10. Proliferation kinetics of recruited cells in a mouse mammary carcinoma.
Pollack A; Terry NH; White RA; Cao S; Meistrich ML; Milas L
Cancer Res; 1994 Feb; 54(3):811-7. PubMed ID: 8306344
[TBL] [Abstract][Full Text] [Related]
11. Improved high-affinity monoclonal antibody to iododeoxyuridine.
Vanderlaan M; Watkins B; Thomas C; Dolbeare F; Stanker L
Cytometry; 1986 Nov; 7(6):499-507. PubMed ID: 3096672
[TBL] [Abstract][Full Text] [Related]
12. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E
Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869
[TBL] [Abstract][Full Text] [Related]
13. DNA double labelling with IdUrd and CldUrd for spatial and temporal analysis of cell proliferation and DNA replication.
Aten JA; Bakker PJ; Stap J; Boschman GA; Veenhof CH
Histochem J; 1992 May; 24(5):251-9. PubMed ID: 1376726
[TBL] [Abstract][Full Text] [Related]
14. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
[TBL] [Abstract][Full Text] [Related]
15. Cell kinetic analysis of mixed populations using three-color fluorescence flow cytometry.
Begg AC; Hofland I
Cytometry; 1991; 12(5):445-54. PubMed ID: 1718673
[TBL] [Abstract][Full Text] [Related]
16. A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.
Eidukevicius R; Characiejus D; Janavicius R; Kazlauskaite N; Pasukoniene V; Mauricas M; Den Otter W
BMC Cancer; 2005 Sep; 5():122. PubMed ID: 16176590
[TBL] [Abstract][Full Text] [Related]
17. Double labeling with iodo- and bromodeoxyuridine for cell kinetics studies.
Shibui S; Hoshino T; Vanderlaan M; Gray JW
J Histochem Cytochem; 1989 Jul; 37(7):1007-11. PubMed ID: 2659659
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical quantitation of bromodeoxyuridine: application to cell-cycle kinetics.
Dolbeare F; Selden JR
Methods Cell Biol; 1994; 41():297-316. PubMed ID: 7861968
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo.
Rodriguez R; Ritter MA; Fowler JF; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):105-13. PubMed ID: 8175417
[TBL] [Abstract][Full Text] [Related]
20. [In vivo evaluation of potential doubling time (Tpot) of tumors by flow cytometry: practical difficulties and possible solutions].
Gorisse MC; Desoize B; Carpentier Y; Nguyen TD
Bull Cancer; 1996 Oct; 83(10):825-34. PubMed ID: 8952632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
